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W e  quan tified  v itam in  A  in  th e  cerebrospinal flu id  o f  p a ­
tien ts w ith  id iopath ic  in tracran ia l hypertension , elevated 
in tracran ia l p ressure o f  o ther causes an d  norm al in tracra­
n ial pressure. V itam in  A  could  be detected  by  high- 
pressure liq u id  ch rom atography  in  m ost o f  th e  speci­
mens. T here  was a significantly  h igher level o f  v itam in  A  
in  th e  cerebrospinal flu id  o f  som e pa tien ts w ith  id io ­
path ic  in tracran ia l hypertension . V itam in  A  toxicity  m ay 
p lay  a role in  th e  pathogenesis o f  id iopath ic  in tracran ia l 
hypertension.
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Idiopathic intracranial hypertension (IIH ) is a condi­
tion  o f  elevated intracranial pressure (ICP) that tends 
to  occur in otherwise healthy overweight young 
w om en. T he underlying cause o f  IIH  is unknow n. V i­
tam in A has been proposed as a candidate m ediator o f 
IIH  because o f  reports o f  vitam in A intoxication asso­
ciated w ith  elevated IC P. Recently, elevated serum ret­
in o l1 and serum retinol-b inding p ro te in2 (RBP) levels 
were found in som e patients w ith  IIH , suggesting that 
IIH  is associated w ith  an abnorm ality  in  the vitam in A 
transport system. V itam in A has no t been measured 
previously in cerebrospinal fluid (CSF). W e explored 
the role o f  vitam in A in the pathophysiology o f  IIH  by 
attem pting  to  detect and quantify  retinol, the major
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circulating form o f  vitam in A, in  the CSF o f patients 
w ith  and w ithou t IIH .
Patients and Methods
We obtained 1ml of CSF from patients undergoing lumbar 
puncture (LP) for various reasons from January 1999 
through August 2001. We recorded the reason for the LP, 
opening pressure, CSF indices, MRI results, presence of pap­
illedema, medications, gender, and age of the patient. In 
most patients, height and weight data were available in the 
chart.
In addition, a group of patients undergoing spinal anes­
thesia for routine surgical procedures consented to have their 
CSF pressure measured and to donate an aliquot of CSF, but 
indices were not analyzed. All CSF was shielded from light 
during collection. The institutional review board of the Uni­
versity o f Utah approved this study.
Patients were grouped based on medical history into three 
categories: (1) IIH, those meeting the modified Dandy cri­
teria of increased ICP, papilledema, normal neuroimaging, 
and no other causes discovered, (2) elevated ICP, those with 
elevated ICP attributable to medical conditions, medication 
use, or venous sinus thrombosis, and (3) normal ICP, those 
having LP for other neurological conditions or spinal anes­
thesia. ICP was considered elevated if the pressure was 
greater than 250mm CSF. Patients with clinically suspected 
breakdown of the blood-brain barrier (BBB) were identified 
based on history of brain tumor or recent neurosurgical pro­
cedure.
High-Pressure L iq u id  Chromatography Analysis o f  
V itam in  A in  Cerebrospinal F lu id  Sam ples 
CSF samples were stored in aliquots o f 0.5ml at — 70°C un­
til analyzed. Under red light and on ice, 0.5ml of CSF and
0.5ml o f methanol were blended thoroughly. Hexane 0.5ml 
containing 0.1% butylated hydroxytoluene as an antioxidant 
was added to the CSF-methanol mixture, which again was 
mixed thoroughly. After centrifugation at 5,000 rpm for 5 
minutes, the upper phase contained hexane with extracted 
retinol. Single-step extraction was sufficient to extract greater 
than 90% of endogenous detectable retinol. Immediately af­
ter extraction, 200|xl o f extracted material was analyzed by 
normal phase HPLC using a DYNAMAX-60A silica column 
(Ranin Instrument, Emeryville, CA). Samples were eluted 
isocratically at a flow rate o f 1.0ml per minute with a mix­
ture of 90% hexane and 10% 1,4-dioxane on a Waters (Mil­
ford, MA) HPLC system with single wavelength detection at 
325nm or on a Thermo Separations (San Jose, CA) HPLC 
system with photodiode array detection. The vitamin A peak 
on the chromatograms was quantified by external standard­
ization against synthetic vitamin A (all-ftw/ic-retinol) from 
Sigma Chemicals (St. Louis, MO). Storage of CSF samples 
at — 70°C in the dark for up to 12 months did not affect 
retinol content.
Statistica l M ethods
Data were entered into Microsoft Excel 97 and imported 
into SPSS 10.0 for Windows for analysis. Summary statistics 
were used to characterize patients participating in this study. 
CSF vitamin A levels were grouped into three ordinal cate­
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gories for analysis: undetectable (< lnM ), moderate 
(l-25nM ), and high (>25nM ). Associations between pa­
tients with III T and vitamin A levels were tested using the 
Fisher’s exact test, with post hoc paired tests conducted using 
a Bonferroni adjusted a . ’
Results
A peak whose elution tim e was the same as the syn­
thetic vitam in A standard was present on m any o f  the 
CSF chrom atogram s (Fig, inset). T h e  identity  o f  this 
peak was confirm ed on pooled CSF samples by pho to ­
diode array detection, which showed an absorption 
spectrum  identical to the vitam in A standard w ith a 
peak absorbance at 326nm . N o retinyl esters or caro­
tenoids were detectable under these conditions. F ur­
therm ore, coinjection o f  a vitam in A -positive CSF 
sam ple with the vitam in A standard yielded a single 
peak on the chrom atogram . T he CSF vitam in A levels 
ranged from 0 to 304nM , w ith a mean o f  14.2nM  and 
a median o f  7 .13nM . T en specimens had no detectable 
vitam in A.
Samples from a total o f  80 patients were included in 
the analyses. See Table 1 for dem ographic inform ation. 
Expected differences were observed for mean age, body 
mass index, the percentage o f  patients w ho were fe­
male, and mean IC P. Four patients were identified as 
having BBB. O f  the 21 patients w ith IIH , 2 did not 
have elevated IC P  at the tim e o f  the LP b u t were in­
cluded in the group because o f  previously having m et 
the D andy criteria. Eighteen o f  those in the elevated 
IC P  group had elevated IC P  because o f  use o f  a m ed­
ication or from a medical condition. Six had venous
outflow  obstruction, four were on tetracycline antibi­
otics, two had pulm onary  disease, and two had cancer 
involving the central nervous system. N ine patients 
gave specimens while undergoing spinal anesthesia 
(11% ). O n e  o f  these patients was included in the ele­
vated IC P  group because o f  asym ptom atic IC P  o f  
336m m  CSF. T he others were included in the norm al 
IC P  group. M ost in the norm al IC P  group were un ­
dergoing LP for conditions such as optic neuropathy, 
m ultiple sclerosis, or headache.
T here was a statistically significant association be­
tween higher vitam in A levels and IIH  (p  =  0.036; 
Table 2 and Fig). V itam in A levels were no t signifi­
cantly associated with increased pressure (p  =  0.31), 
body mass index (p  =  0 .120), or w ith the presence o f  
abnorm al CSF param eters o f  elevated protein (p  =  
0.382), erythrocytes (p  =  0.153), or leukocytes (p  =  
0.936). H igher vitam in A levels were m arginally signif­
icantly associated w ith female gender (p  =  0.094) and 
younger age (p  =  0.069). T h e  average vitam in A level 
in the four patients w ith BBB was 23 .0nM . T he small 
size o f  the group did no t perm it statistical analysis. T he 
average vitam in A level in the nine patients undergoing 
spinal anesthesia was 5.9nM . T here was no association 
between m ultivitam in use and level o f  vitam in A.
Discussion
Serum RBP and retinol have been found to be elevated 
in som e patients with I IH .1 2 Retinol is actively trans­
ported across the BBB by transthyretin , in a complex 
w ith R B P.4 RBP has been found to  localize to the hu-
Fig. Scattergram o f  serum retinol lei>els 
showing noi~mal intracranial pressure (ICP), 
elevated ICP, and idiopathic intracranial 
hypertension (IIH). The horizontal bar rep­
resents the median value. The boxes repre­
sent the 75th and  25th percentiles, and the 
whiskers represent the 95th and 5th percen­
tiles. The filled  dots denote the patients with 
blood—brain barrier. The inset box is an 
high-petformance liquid chromatogram o f  
extracted vitamin A  fi-om pooled cerebrospi­
nal flu id  samples fiv m  three subjects, and its 
inset box displays the photodiode array spec­
trum o f  the peak eluting at 21 minutes that 
coelutes with vitamin A  standard and whose 
absorbance maximum at 326nm  matches 
that o f  synthetic vitamin A.
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Table 1. Characteristics o f  S tudy P atien ts
Characteristic IIII (n =  20) E-ICP (n =  19) N-ICP (n =  39) Totals (n =  78) P
Agc“ (yr) 26.0 (21.5-38.0) 34.0 (22.0-52.0) 48.5 (39.3-63.3) 40.0 (24.3-52.8) < 0.001
BMP'1’ (kg/m2) 33.5 (31.1-41.4) 32.8 (28.0-36.1) 26.3 (23.4-31.2) 29.4 (24.4-36.1) <0.003
Female1' (%) 100.0 84.2 55 73.8 < 0.001
Opening pressure;4,d (mm CSF) 318 (281-458) 350 (310-390) 183 (152-205) 240 (177-338) < 0.001
Multivitamin usec,d (%) 0 10.5 30 17.5 0.005
CSF retinol levels14 (nM) 8.0 (4.7-22.4) 7.5 (2.8-9.3) 6.2(2.6-12.7) 7.13(3.1-11.9) 0.470
“M edian (interquartile range), group com parison using Kruskal—Wallis test. 
bn =  56 (IIH , n =  15; E-ICP, n =  12; N -IC P, n =  29). 
l G roup com parison using Fisher’s exact test. 
dn =  78 (IIH , n =  20;"F.-1CP, n =  19; N -IC P, n =  39).
IIH  =  idiopathic intracranial hypertension; F.-1CP =  elevated intracranial pressure; N -IC P  =  norm al ICP; BM I =  body mass index; CSF =  
cerebrospinal fluid.
Table 2. Association between I IH  and Vitamin A  levels“
Vitamin A
Level IIII, E-ICP, N-ICP, Total,
(nM) f (%) f (%) f (%) f (%)
<1 1 (10.0) 3 (30.0) 6 (60.0) 10 (100.0)
1-25 15 (23.4) 16 (25.0) 33 (51.6) 64(100.0)
>25 5 (83.3) 0 (0 .0) 1 (16.7) 6 (100.0)
Total 21 (26.3) 19 (23.8) 40 (50.0) 80 (100.0)
“Using Fisher’s exact test, p  = 0.036. Paired com parisons using a 
Bonferroni adjustm ent (a =  0.0167) were not significant (IIH  vs 
F.-1CP, p  =  0.048; IIH  vs N -IC P, p  =  0.021; E-IC P vs N -IC P, 
p = 1.000).
IIH  =  idiopathic intracranial hypertension; F.-1CP =  elevated in­
tracranial pressure; N -IC P  =  norm al ICP.
m an choroid plexus epithelium  and to  endothelial cells 
o f  brain  m icrovasculature.5 V itam in A  therefore is 
though t to  have a specific transport m echanism  into 
the CSF. R etinol and its m etabolite retinoic acid play 
an im portan t role n o t only in  developing brain, bu t 
also in  transneuronal signaling in  the basal ganglia and 
associated structures in  the m ature b rain .6 However, 
retinol is though t to  be toxic to  m em branes w hen its 
level exceeds the b ind ing  capacity o f  R B P.7
Excess RBP and retinol in the serum may be trans­
ported into the CSF where retinol acts as a toxin to the 
arachnoid granulation resorption mechanism. The finding 
o f  high vitamin A  in the CSF o f some patients w ith IIH  
would support this theory, as would the high average vi­
tam in A  level in patients w ith BBB. H igh CSF vitamin A  
found in  IIH  may represent an epiphenom enon or 
marker o f  excess CSF production by the choroid plexus.
O f  interest are several observations. O n e  patient 
w ith  chronic daily headaches and borderline elevated 
IC P  w ithou t papilledem a had three samples analyzed. 
H er CSF vitam in A  was consistent over tim e (4.59, 
4 .86, and 5 .97nM ). A nother patient had two LP, one 
while sym ptom atic w ith  IIH  (65.1 nM ), and another 
w hen sym ptom s and signs o f  IIH  had resolved
(5 .07nM ). O n e  patien t w ith  headaches attributed to 
isotretinoin had norm al IC P  (210m m  CSF), and a 
CSF vitam in A  o f  5.8nM .
In  this study, we dem onstrate detection o f  retinol in 
spinal fluid. Some patients w ith  IIH  had statistically 
significantly higher levels o f  vitam in A  than  patients 
w ith  norm al IC P  or patients w ith  other causes o f  ele­
vated IC P. V itam in A  levels were no t fully explained 
by the age, gender, m ultiv itam in use, body mass index, 
or IC P o f  the patients.
Further research is needed to study the association be­
tween CSF vitam in A  levels and IIH . Studies should in­
clude patients w ith  bo th  low (< 1 n M ) and high 
(> 2 5 n M ) vitam in A  levels to determ ine w hether the ob­
served relationship w ith  IIH  remains consistent. M any 
m ore subjects undergoing spinal anesthesia should be 
studied, to ascertain a norm al range o f  vitam in A. M ea­
surem ent o f  other metabolites such as retinoic acid in 
the serum (or CSF) m ight be revealing.8 D etection and 
quantification o f  RBP in the CSF also may prove fruit­
ful in  elucidating in  the pathophysiology o f  IIH . 
M atched specimens o f  serum and CSF vitam in A  and 
RBP should be analyzed. Further study o f  patients w ith 
BBB could shed light on  the regulation o f  vitam in A  
transport and metabolism in the central nervous system. 
There is no question, however, that vitam in A  can be 
detected in  CSF in m any individuals, and our results 
indicate a higher level in  some patients w ith  IIH .
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T h a l a m i c  N e urodegeneration  
in Multiple Sclerosis
Alberto Cifelli, M D ,1'2 Marzena Arridge, PhD,1
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M ultip le  sclerosis is still regarded p rim arily  as a disease 
o f  the w hite  m atter. H ow ever, recent evidence suggests 
th a t there  m ay be significant involvem ent o f  g ray  m atter. 
H ere, we have used m agnetic resonance im aging and 
m agnetic resonance spectroscopy in vivo and  h is topatho l- 
ogy postm ortem  to estim ate thalam ic neu ronal loss in p a ­
tien ts w ith  m ultip le  sclerosis. O u r results show  th a t neu ­
ronal loss in  m ultip le  sclerosis can be substan tial (3 0 ­
35%  reduction). W e conclude th a t a neurodegenerative 
patho logy  m ay m ake a m ajor con tribu tion  to  the genesis 
o f  sym ptom s in m ultip le  sclerosis.
Ann Neurol 2002;52:650-653
W ith  an increasing locus on axonal injury  and transec­
tion  as the m ain cause of chronic disability w ith m ul­
tiple sclerosis (M S),1’2 atten tion  also has tu rned to  un-
Hrom the ‘C entre feir Hunctional M agnetic Resonance Im aging o f  
the Brain, and ^D epartm ent o f  Clinical Neurology, University o f  
Oxford, Oxford, U nited  Kingdom.
Received M ar 18, 2002, and in revised form May 28. Accepted feir 
publication May 28, 2002.
Published online Aug 25, 2002, in Wilev InterScience 
(www.interscience.wilev.com). D O I: 10.1002/ana. 10326
Address correspondence to D r M atthews, Centre for Hunctional 
M agnetic Resonance Im aging o f  the Brain, Jo h n  Ridcliffe Hospital, 
Headley W ay, H eadington, O xford O X 3 9D U , U nited Kingdom .
F.-mail: paul<®fmrib.ox.ac.uk
derstanding neuronal pathology in gray m atter (GM ) 
of patients w ith  MS, particularly to  explain cognitive 
sym ptom s.3 A xotom y is associated w ith  retrograde neu­
ronal degeneration and apoptosis.4 A poptosis of retinal 
ganglion cells is associated w ith  optic neuritis in a ro­
den t experim ental allergic encephalitis m odel.5 G M  
also m ay be a com m on focus for inflam m atory dam - 
age.6
T he aim of our study was to  assess the extent of 
neuronal loss in thalam ic G M  of patients w ith  MS us­
ing im aging m ethods and then to  validate the measure­
m ents w ith  parallel histopathological studies perform ed 
on (different) postm ortem  material. T he thalam ic m e­
dial dorsal (M D ) nucleus specifically was chosen for 
the histopathological study because of its relatively 
large size, clearly defined boundaries, and po tential im ­
portance for understanding cognitive m anifestations of 
M S.7
Subjects and Methods
Magnetic Resonance Spectroscopy and Imaging 
Magnetic resonance studies were conducted for 14 secondary 
progressive MS patients randomly selected from our clinic 
database (Table 1). Healthy controls were age- and gender- 
matched. Subjects had a structural magnetic resonance imag­
ing for thalamic volume measurements with a pulse sequence 
optimized for contrast between the thalamus and surround­
ing white matter and magnetic resonance spectroscopy of the 
thalamus. Informed consent was obtained.
All studies were performed using a 3T Varian-Inova 
scanner (Varian N M R Instruments, Inc., Palo Alto, CA). 
For volume measurements, a three-dimensional 
magnetization-prepared fast gradient echo sequence (inver­
sion recovery time TI, 500 milliseconds; TE, 5 millisec­
onds; TR, 30 milliseconds; 64 X 3mm) was used. Tha­
lamic and intracranial volumes were outlined manually in 
the coronal plane (Fig, A and B). Ratios o f thalamic vol­
ume to intracranial volume were calculated in every patient 
(multiplied by 106 for a normalized thalamic volume 
[NTV]). Third ventricle width was measured from the 
coronal slice showing maximum width.
Proton magnetic resonance spectra were acquired using a 
localized PRESS sequence8 (echo time TE, 26 milliseconds; 
repetition time TR, 5 seconds) and a W ET9 water suppres­
sion scheme. The use of a short echo time and a TR long 
enough to allow full relaxation minimized the effects of 
modest changes in relaxation times (eg, from factors such as 
increased iron content) on measurements of metabolite con­
centrations. Application of a specially designed 90 degree RF 
pulse in PRESS allowed simultaneous acquisition of the sig­
nal from two cubical approximately 1cm ’ volumes of interest 
placed in the thalami. Metabolite concentrations were esti­
mated (VARPRO method and MRUI software) using brain 
tissue water as a concentration reference.10'11 We confirmed 
that similar results were obtained using LCModel.12 The rel­
ative volumes of water in cerebrospinal fluid and tissue com­
partments within the voxel were estimated with biexponen­
tial fitting of the water signal T2 decay (TR, 15 seconds; TE,
650 © 2002 Wiley-Liss, Inc.
